• On June 2, 2026, Zions Bancorporation, N.A. expanded its board from 11 to 12 directors and elected retired PwC banking specialist Daniel J. Ryan, assigning him to the Audit and Risk Oversight Committees effective July 1, 2026.
• By adding a director with decades of experience in governance, regulatory engagement, and cybersecurity risk, Zions is signaling a stronger emphasis on board-level oversight of complex audit and risk issues.
• With Zions pairing its new share repurchase authorization and enhanced board-level risk expertise, we'll examine how this reshapes its investment narrative.

This technology could replace computers: discover 30 stocks that are working to make quantum computing a reality.

Zions Bancorporation National Association Investment Narrative Recap

To own Zions Bancorporation, N.A., you need to be comfortable with a regional bank that leans heavily on Western U.S. markets and a sizable commercial real estate book, while using buybacks and dividends to support shareholder returns. The Daniel J. Ryan board appointment modestly reinforces oversight of audit, risk, and cybersecurity, but it does not materially alter the near term focus on credit quality and deposit costs as the key catalyst and risk.

The most relevant recent announcement alongside Ryan’s election is the new share repurchase authorization of up to US$225 million through 2026, which sits against an updated fair value estimate of US$68.75. Together, capital returns and enhanced board level risk expertise frame how investors might weigh Zions’ current valuation against its exposure to regional economic and commercial real estate cycles.

Yet while the board is strengthening its risk credentials, investors should still be aware of Zions’ 22 percent CRE loan concentration and the possibility that...

Zions Bancorporation National Association's narrative projects $3.8 billion revenue and $970.4 million earnings by 2029. This requires 3.8% yearly revenue growth and a $24.4 million earnings increase from $946.0 million today.

Uncover how Zions Bancorporation National Association's forecasts yield a $68.75 fair value, a 9% upside to its current price.

Exploring Other Perspectives

Three members of the Simply Wall St Community see fair value anywhere from US$68.75 to US$44,072.55, underscoring how far opinions can stretch. Against that backdrop, Zions’ concentrated Western U.S. footprint and 22 percent CRE exposure give you important context for judging which scenarios feel realistic and why it is worth comparing several viewpoints before acting.

Explore 3 other fair value estimates on Zions Bancorporation National Association - why the stock might be a potential multi-bagger!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Zions Bancorporation National Association research is our analysis highlighting 4 key rewards that could impact your investment decision.
• Our free Zions Bancorporation National Association research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Zions Bancorporation National Association's overall financial health at a glance.

Contemplating Other Strategies?

Our top stock finds are flying under the radar-for now. Get in early:

• The latest GPUs need a type of rare earth metal called Neodymium and there are only 27 companies in the world exploring or producing it. Find the list for free.
• Find 48 companies with promising cash flow potential yet trading below their fair value.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 13 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.